Literature DB >> 18370861

HPLC-MS/MS in drug metabolism and pharmacokinetic screening.

Yunsheng Hsieh1.   

Abstract

During the lead optimization stages, one common requirement for many processes is the need for bioanalytical support. This review summarizes high performance liquid chromatography coupled to a tandem mass spectrometer (HPLC-MS/MS) methodologies that are employed in drug metabolism and pharmacokinetic screens for a series of new chemical entities. The HPLC-MS/MS methods for trace organic quantitative determinations to support both in vitro and in vivo experiments and for the qualitative assays, such as metabolite identification, are presented. The challenges of performing HPLC-MS/MS assays, such as the choice of ionization sources, matrix ionization suppression and the potential for endogenous interferences, are also addressed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18370861     DOI: 10.1517/17425255.4.1.93

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  5 in total

1.  SILEC: a protocol for generating and using isotopically labeled coenzyme A mass spectrometry standards.

Authors:  Sankha S Basu; Ian A Blair
Journal:  Nat Protoc       Date:  2011-12-08       Impact factor: 13.491

2.  The Application of Mass Spectrometry in Drug Metabolism and Pharmacokinetics.

Authors:  Ji-Yoon Lee; Sang Kyum Kim; Kiho Lee; Soo Jin Oh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Antifolate-induced depletion of intracellular glycine and purines inhibits thymineless death in E. coli.

Authors:  Yun Kyung Kwon; Meytal B Higgins; Joshua D Rabinowitz
Journal:  ACS Chem Biol       Date:  2010-08-20       Impact factor: 5.100

4.  Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[Bis(2-Chlorophenyl)Methyl]-3-(2-Pyrimidinyl)-8-Azabicyclo[3.2.1]Octan-3-Ol) in preclinical models.

Authors:  Robbie L McLeod; Deen B Tulshian; Donald C Bolser; Geoffrey B Varty; Marco Baptista; Xiomara Fernandez; Leonard E Parra; Jennifer C Zimmer; Christine H Erickson; Ginny D Ho; Yanlin Jia; Fay W Ng; Walter Korfmacher; Xiaoying Xu; John Veals; April Smith-Torhan; Samuel Wainhaus; Ahmad B Fawzi; Theodore M Austin; Margaret van Heek; John A Hey
Journal:  Eur J Pharmacol       Date:  2009-12-16       Impact factor: 4.432

5.  A domino effect in antifolate drug action in Escherichia coli.

Authors:  Yun Kyung Kwon; Wenyun Lu; Eugene Melamud; Nurussaba Khanam; Andrew Bognar; Joshua D Rabinowitz
Journal:  Nat Chem Biol       Date:  2008-08-24       Impact factor: 15.040

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.